Schadt, Oliver,Esdar, Christina,Schultz-Fademrecht, Carsten,Eickhoff, Jan
申请号：
AU2014277262
公开号：
AU2014277262B2
申请日:
2014.05.07
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The compound N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-5-ethyl-1-(pyrimidin-5-yl)-1 H-pyrazole-4-carboxamide and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios, is an inhibitor of RON and can be employed, for the treatment of cancer.
